Barclays Reaffirms Overweight Rating on Equity LifeStyle Properties SoftBank Group Surges 61 Billion in Market Cap Over Two Days on AIFueled Optimism AI Could Revolutionize Brain Drug Discovery Slashing Timelines from Decades to Years Czech Police Orders 11 Airbus H145 Helicopters in Fleet Modernization Deal Kazatomprom Reports 17 Production Surge in Third Quarter Bolstering Uranium Supply Outlook Microsoft Shares Decline Historical SellOffs Have Often Preceded Recoveries Root Inc ROOT Q1 2026 Earnings Massive EPS Beat as Underwriting Improvements Drive Profitability Via Transportation Inc VIA Q1 2026 Earnings EPS Surprises Positively Amid Revenue Silence PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Evotec Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement AREC Q3 2025 Earnings SmallerThanExpected Loss Signals Operational Progress Shoulder Innovations Inc SI Q1 2026 Earnings NarrowerthanExpected Loss Despite No Reported Revenue CECO Environmental Surges Nearly 10 in Strong Uptrend BioHarvest Sciences Inc BHST Edges Higher as Price Approaches Resistance After Support Test Titan Machinery TITN Slips 109 as Shares Hover Near Key Support Eaton Vance Short Duration Income Fund EVG Holds Steady Near Key Support After Slight Decline Gold Resource Corporation GORO Surges on Bullish Momentum Eyes Resistance at 144 MidMarket PE Fundraising Shows Recovery but Smaller Managers May Still Face Challenges Murphy USA Inc MUSA Q1 2026 Earnings Earnings Surge Past Estimates Stock Slips Marginally Caesars Entertainment CZR Advances Slightly Nears Key Resistance at 3053 BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Execution AON Q1 2026 Earnings EPS Surpasses Estimates by 029 OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss EONR Q2 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress ZENA Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction GitLab Q1 2026 Earnings EPS Beat Drives Stock Uptick Pasithea Therapeutics KTTA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction